Company Overview
IONIS PHARMACEUTICALS INC
IONSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
944M
2025 FY
Net Income
-381M
2025 FY
Shares Outstanding
160M
2025 FY
EPS
-2.38USD
2025 FY
Company Information
SIC Code
2834
CIK Code
874015
Exchange
Nasdaq
Location
US